Nissin Foods Announces 2026 Interim Results

 Financial HighlightsFor the six months ended 30 June 2026(HK$ million)20262025ChangeRevenue2,071.02,014.2+2.8%Gross Profit731.0677.0+8.0%Gross Profit margin35.3%33.6%+1.7ppProfit attributable to owners of the Company175.2157.0+11.6%Net profit margin8.5%7.8%+0.7ppAdjusted EBITDA330.8303.2+9.1%Earnings per share (HK cents)16.7915.05+11.6%HONG KONG, August 25, 2026 - (ACN Newswire via SeaPRwire.com) - Nissin Foods Company Limited (“Nissin Foods” or the “Company”, together with its subsidiaries, the…

Mitsubishi Research Institute and Hitachi Partner to Launch Advanced Power Trading Service for Extra-High-Voltage Grid-Scale-Battery Operators

TOKYO, August 27, 2026 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Research Institute, Inc. (TSE:3636, “MRI”) and Hitachi, Ltd. (TSE:6501, "Hitachi") signed a Memorandum of Understanding (MoU) on 25 August to build a cooperative framework for delivering advanced power-trading support services tailored to grid-scale battery operators in the extra-high voltage segment,…

Newly Developed “Two-Motor Hybrid Drive Module” Adopted for STELLANTIS New “Jeep Cherokee”

KARIYA, JAPAN, August 27, 2026 - (JCN Newswire via SeaPRwire.com) - BluE Nexus Corporation (Headquarter: Anjo City, Aichi Prefecture; President: Hidetoshi Uchiyama; hereinafter “BluE”), AISIN Corporation (Headquarter: Kariya City, Aichi Prefecture; President: Moritaka Yoshida; hereinafter “AISIN”), and DENSO Corporation (Headquarter: Kariya City, Aichi Prefecture; President: Shinnosuke Hayashi; hereinafter “DENSO”) have jointly…

LEQEMBI IQLIK(R) (lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer’s Disease

TOKYO and CAMBRIDGE, Mass., August 27, 2026 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB, announced today that once weekly lecanemab-irmb subcutaneous injection (brand name: LEQEMBI IQLIK®)is now available in the U.S. for initiation therapy for early Alzheimer’s disease (AD) in adults with mild cognitive…

Overseas Growth Gathers Momentum as CanSinoBIO’s Global Strategy Unlocks New Opportunities

HONG KONG, August 27, 2026 - (ACN Newswire via SeaPRwire.com) - CanSino Biologics Inc. (“CanSinoBIO,” 06185.HK/688185.SH) released its financial results for the first half of 2026. The Company reported revenue of approximately RMB 550 million, up 43.8% year on year, while its net loss attributable to shareholders narrowed significantly.  Notably, while…

Trio Group (1710.HK) Announces 2026 Interim Results with Revenue at approximately HK$337.5 million; Unveils “Stations as Media, Media Empowers Energy” Core Strategy

EQS via SeaPRwire.com / 27/08/2026 / 22:06 UTC+8 【For Immediate release】     Trio Industrial Electronics Group Limited (Stock Code: 1710.HK)   Announces 2026 Interim Results*  *  * Recorded Revenue at approximately HK$337.5 million andProposed Interim Dividend of HK0.8 cent per share Unveils “Stations as Media, Media Empowers Energy” Core…